Occlutech

mVSD Occluder

Designed for safety and excellence

Muscular Ventricular Septal Defects (mVSDs)

Muscular Ventricular Septal Defects (mVSDs) are entirely located in the muscular portion of the ventricular septum, and can be further classified in order of their frequency into apical, mid-septal, anterior and posterior defects.

Dedicated design for mVSD closure with long waist which accommodates the muscular ventricular septum.
Symmetrical discs allow a smooth alignment over the defect.
Unique braiding technology, soft and atraumatic device.
Short disc rims exert minimum pressure on the surrounding tissue and cardiac structures.
No distal hub, less material, less protrusion.
Repositionable and fully retrievable.

For product specifications, please call our customer service team on
+256 393 255613

2018_Kenny - A randomised, controlled, multi-center trial of the efficacy and safety of the Occlutech Figuila Flex-II Occluder compared to the Amplatzer Septal Occluder for Transcatheter Closure of secondum Atrial Septum defects.
Castleman LS et.al. Biocompatibility of Nitinol Alloy as an Implant material. Journal of Biomedical Materials Research 976; 10 : 695
Electrochemical characterization of Nitinol occluder, Natural and Medical Sciences Institute at the University of Tubingen.
Eurointervention - Amplatzer versus Figuila for transcatheter Patent Faramen Ovale Closure.

mVSD Occluder

Muscular Ventricular Septal Defects (mVSDs)

Daraja Health Care is redefining the face of patient care in Uganda. We are a science led company, tech-enabled and data driven.

Work Hours

Compliance

Contact Us

Connect With Us: